These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

403 related articles for article (PubMed ID: 35543110)

  • 21. Correlates of Adherence to Oral and Vaginal Pre-exposure Prophylaxis (PrEP) Among Adolescent Girls and Young Women (AGYW) Participating in the MTN-034/REACH Trial.
    Ngure K; Browne EN; Reddy K; Friedland BA; van der Straten A; Palanee-Phillips T; Nakalega R; Gati B; Kalule HN; Siziba B; Soto-Torres L; Nair G; Garcia M; Celum C; Roberts ST
    AIDS Behav; 2024 Sep; 28(9):2990-3000. PubMed ID: 38852114
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Early antiretroviral therapy and daily pre-exposure prophylaxis for HIV prevention among female sex workers in Cotonou, Benin: a prospective observational demonstration study.
    Mboup A; Béhanzin L; Guédou FA; Geraldo N; Goma-Matsétsé E; Giguère K; Aza-Gnandji M; Kessou L; Diallo M; Kêkê RK; Bachabi M; Dramane K; Geidelberg L; Cianci F; Lafrance C; Affolabi D; Diabaté S; Gagnon MP; Zannou DM; Gangbo F; Boily MC; Vickerman P; Alary M
    J Int AIDS Soc; 2018 Nov; 21(11):e25208. PubMed ID: 31291057
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Retention, engagement, and adherence to pre-exposure prophylaxis for men who have sex with men and transgender women in PrEP Brasil: 48 week results of a demonstration study.
    Grinsztejn B; Hoagland B; Moreira RI; Kallas EG; Madruga JV; Goulart S; Leite IC; Freitas L; Martins LMS; Torres TS; Vasconcelos R; De Boni RB; Anderson PL; Liu A; Luz PM; Veloso VG;
    Lancet HIV; 2018 Mar; 5(3):e136-e145. PubMed ID: 29467098
    [TBL] [Abstract][Full Text] [Related]  

  • 24. PrEP uptake, persistence, adherence, and effect of retrospective drug level feedback on PrEP adherence among young women in southern Africa: Results from HPTN 082, a randomized controlled trial.
    Celum C; Hosek S; Tsholwana M; Kassim S; Mukaka S; Dye BJ; Pathak S; Mgodi N; Bekker LG; Donnell DJ; Wilson E; Yuha K; Anderson PL; Agyei Y; Noble H; Rose SM; Baeten JM; Fogel JM; Adeyeye A; Wiesner L; Rooney J; Delany-Moretlwe S
    PLoS Med; 2021 Jun; 18(6):e1003670. PubMed ID: 34143779
    [TBL] [Abstract][Full Text] [Related]  

  • 25. HIV pre-exposure prophylaxis for men who have sex with men in west Africa: a multicountry demonstration study.
    Laurent C; Dembélé Keita B; Yaya I; Le Guicher G; Sagaon-Teyssier L; Agboyibor MK; Coulibaly A; Traoré I; Malan JB; De Baetselier I; Eubanks A; Riegel L; Rojas Castro D; Fayé-Ketté H; Koné A; Diandé S; Dagnra CA; Serrano L; Diallo F; Mensah E; Dah TTE; Anoma C; Vuylsteke B; Spire B;
    Lancet HIV; 2021 Jul; 8(7):e420-e428. PubMed ID: 34048794
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Policy considerations for scaling up access to HIV pre-exposure prophylaxis for adolescent girls and young women: Examples from Kenya, South Africa, and Uganda.
    Lane J; Brezak A; Patel P; Verani AR; Benech I; Katz A
    Int J Health Plann Manage; 2021 Sep; 36(5):1789-1808. PubMed ID: 34159630
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High PrEP uptake and objective longitudinal adherence among HIV-exposed women with personal or partner plans for pregnancy in rural Uganda: A cohort study.
    Matthews LT; Atukunda EC; Owembabazi M; Kalyebera KP; Psaros C; Chitneni P; Hendrix CW; Marzinke MA; Anderson PL; Isehunwa OO; Hurwitz KE; Bennett K; Muyindike W; Bangsberg DR; Haberer JE; Marrazzo JM; Bwana MB
    PLoS Med; 2023 Feb; 20(2):e1004088. PubMed ID: 36795763
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A multi-country cross-sectional study to assess predictors of daily versus on-demand oral pre-exposure prophylaxis in youth from South Africa, Uganda and Zimbabwe.
    Dietrich JJ; Ahmed N; Webb EL; Tshabalala G; Hornschuh S; Mulaudzi M; Atujuna M; Stranix-Chibanda L; Nematadzira T; Ssemata AS; Muhumuza R; Seeley J; Bekker LG; Weiss HA; Martinson N; Fox J;
    J Int AIDS Soc; 2022 Aug; 25(8):e25975. PubMed ID: 36002910
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intimate partner violence and oral HIV pre-exposure prophylaxis adherence among young African women.
    Giovenco D; Pettifor A; Powers KA; Hightow-Weidman L; Pence BW; Celum C; Delany-Moretlwe S; Hosek S; Donnell D; Anderson PL; Mgodi N; Bekker LG
    AIDS; 2022 Jul; 36(8):1151-1159. PubMed ID: 35579012
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Uptake and retention on HIV pre-exposure prophylaxis among key and priority populations in South-Central Uganda.
    Kagaayi J; Batte J; Nakawooya H; Kigozi B; Nakigozi G; Strömdahl S; Ekström AM; Chang LW; Gray R; Reynolds SJ; Komaketch P; Alamo S; Serwadda D
    J Int AIDS Soc; 2020 Aug; 23(8):e25588. PubMed ID: 32785976
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Factors that influence adolescent girls and young women's re-initiation or complete discontinuation from daily oral PrEP use: a qualitative study from Eastern Cape Province, South Africa.
    de Vos L; Mudzingwa EK; Fynn L; Atujuna M; Mugore M; Gandhi M; Celum C; Hosek S; Bekker LG; Daniels J; Medina-Marino A
    J Int AIDS Soc; 2023 Sep; 26(9):e26175. PubMed ID: 37758649
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prospective study of oral pre-exposure prophylaxis initiation and adherence among young women in KwaZulu-Natal, South Africa.
    Mansoor LE; Lewis L; Naicker CL; Harkoo I; Dawood H; Naidoo K; Gengiah TN; Samsunder N; Beesham I; Abdool Karim SS; Abdool Karim Q
    J Int AIDS Soc; 2022 Jul; 25(7):e25957. PubMed ID: 35785472
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Experiences of oral pre-exposure prophylaxis (PrEP) use disclosure among South African adolescent girls and young women and its perceived impact on adherence.
    Giovenco D; Gill K; Fynn L; Duyver M; O'Rourke S; van der Straten A; Morton JF; Celum CL; Bekker LG
    PLoS One; 2021; 16(3):e0248307. PubMed ID: 33667264
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Assessing longitudinal patterns of depressive symptoms and the influence of symptom trajectories on HIV pre-exposure prophylaxis adherence among adolescent girls in the HPTN 082 randomized controlled trial.
    Velloza J; Hosek S; Donnell D; Anderson PL; Chirenje M; Mgodi N; Bekker LG; Delany-Moretlwe S; Celum C;
    J Int AIDS Soc; 2021 Jun; 24 Suppl 2(Suppl 2):e25731. PubMed ID: 34164929
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A community-based mobile clinic model delivering PrEP for HIV prevention to adolescent girls and young women in Cape Town, South Africa.
    Rousseau E; Bekker LG; Julies RF; Celum C; Morton J; Johnson R; Baeten JM; O'Malley G
    BMC Health Serv Res; 2021 Aug; 21(1):888. PubMed ID: 34454505
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluating the use of oral pre-exposure prophylaxis among pregnant and postpartum adolescent girls and young women in Cape Town, South Africa.
    Khadka N; Gorbach PM; Nyemba DC; Mvududu R; Mashele N; Javanbakht M; Nianogo RA; Aldrovandi GM; Bekker LG; Coates TJ; Myer L; Joseph Davey DL
    Front Reprod Health; 2023; 5():1224474. PubMed ID: 37795521
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Understanding and measuring uptake and coverage of oral pre-exposure prophylaxis delivery among adolescent girls and young women in sub-Saharan Africa.
    Dunbar MS; Kripke K; Haberer J; Castor D; Dalal S; Mukoma W; Mullick S; Patel P; Reed J; Subedar H; Were D; Warren M; Torjesen K
    Sex Health; 2018 Nov; 15(6):513-521. PubMed ID: 30408431
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pre-exposure prophylaxis in real life: experience from a prospective, observational and demonstration project among men who have sex with men in Benin, West Africa.
    Diabaté S; Béhanzin L; Guédou FA; Goma-Matsétsé E; Olodo M; Aza-Gnandji M; Dossouvo A; Akpaka A; Chagas E; Gangbo F; Zannou DM; Alary M
    J Int AIDS Soc; 2023 Jun; 26(6):e26130. PubMed ID: 37306106
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Factors associated with long-term HIV pre-exposure prophylaxis engagement and adherence among transgender women in Brazil, Mexico and Peru: results from the ImPrEP study.
    Konda KA; Torres TS; Mariño G; Ramos A; Moreira RI; Leite IC; Cunha M; Jalil EM; Hoagland B; Guanira JV; Benedetti M; Pimenta C; Vermandere H; Bautista-Arredondo S; Vega-Ramirez H; Veloso VG; Caceres CF; Grinsztejn B;
    J Int AIDS Soc; 2022 Oct; 25 Suppl 5(Suppl 5):e25974. PubMed ID: 36225148
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Alignment of adherence and risk for HIV acquisition in a demonstration project of pre-exposure prophylaxis among HIV serodiscordant couples in Kenya and Uganda: a prospective analysis of prevention-effective adherence.
    Haberer JE; Kidoguchi L; Heffron R; Mugo N; Bukusi E; Katabira E; Asiimwe S; Thomas KK; Celum C; Baeten JM
    J Int AIDS Soc; 2017 Jul; 20(1):21842. PubMed ID: 28741331
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.